Sponsor study identifier
observational
30
1 country
1
Study Start
November 2012
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
July 2014
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
Not reported
Date not reportedFluid responsiveness (FR)refers to the ability of heart to increase its stroke volume in response to volume load.Low tidal volume and high PEEP exerts contrast effect on the prediction of fluid responsiveness, the aim of this study is to compare the relative predicting power of the dynamic preload indicator (PPV, SVV), passive leg raising test, and pleth variability index (PVI) on the fluid responsiveness of acute respiratory distress syndrome ventilated with various PEEP levels or various tidal volumes.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 26, 2012
Actual (reported)October 30, 2012
Actual (reported)November 2012
Date type not reportedThis date has not been verified as actual or estimated.
July 2014
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
increase of cardiac output after volume expansion
Patients are classified to be volume expansion responders or nonresponders according to whether the volume expansion induced cardiac index increase at the end of hydroxyethyl starch infusion is ≧15% or \< 15% of baseline cardiac index.
4 hours
acute respiratory distress syndrome with acute circulatory failure with infusion of 6% tetrastarch for a total of 500ml
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
mechanically ventilated ALL/ARDS patients conforming to the American European Consensus Conference criteria with acute circulatory failure for whom the attending clinician had decided to administer fluid will be enrolled.This decision was based on the presence of at least one clinical sign of inadequate tissue perfusion in the absence of contraindication for fluid infusion.
Chang Gung Memorial Hospital
Taipei, Taiwan, 10507, Taiwan
Chung-Chi Huang, MD
Chang Gung Memorial Hospital
First Submitted
October 26, 2012
First Posted
October 30, 2012
Study Start
November 2012
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
July 2014
Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START)
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
December 3, 2012
Record last verified: 2012-11
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: